Where do I actually start with AI at my biotech?
The honest first move is not a tool or a task force. It is one workflow, one owner, and one real question.
I get this one almost every day, usually from a CEO who has already been pitched ten platforms and is no closer to an answer.
Here is the honest version. Do not start with a tool. Do not start with a task force, a strategy offsite, or a backlog of three hundred use cases. Those all feel like progress and produce none.
Start with one workflow that matters. Not the easiest one, and not the one with the loudest AI request. One that carries real weight for the science or the business. Give it a single owner whose job is the outcome, not the software. Then ask two questions about it. If we designed this today, knowing what these systems can now do, what would we build? And what is actually stopping us, a hard constraint or a habit we inherited?
The gap between those two answers is your starting point. It is concrete, it belongs to someone, and it will teach you more about transforming your company than any platform demo. Do that once, learn from it, and do it again. That is the whole method, and it is why I called this translational intelligence in the first place.
If you want the long version, read The Biotech of Tomorrow and Permission, People, Programs.
Cheers,
-Titus
Get it in your inbox.
New Issues, FAQs, and Case Studies as they go out. Each one names something, explains something, or hands you something you can use on Monday. Subscribe, and I will send each as it goes out.
Prefer the tool you already think in? Here is how to read it in your chatbot.